Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil Patent Expiration
Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil is Used for lowering high blood pressure. It was first introduced by Cosette Pharmaceuticals Inc
Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil Patents
Given below is the list of patents protecting Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Tribenzor |
US5616599 (Pediatric) | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
Oct 25, 2016
(Expired) | Cosette |
| Tribenzor | US5616599 | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
Apr 25, 2016
(Expired) | Cosette |
Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil's Family Patents
Explore Our Curated Drug Screens
Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil Generic API Manufacturers
Several generic applications have been filed for Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil. The first generic version for Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil was by Torrent Pharmaceuticals Ltd and was approved on Oct 26, 2016. And the latest generic version is by Piramal Healthcare Uk Ltd and was approved on May 14, 2025.
Given below is the list of companies who have filed for Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil generic, along with the locations of their manufacturing plants worldwide.
1. ENDO OPERATIONS
Endo Operations Ltd has filed for 5 different strengths of generic version for Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil. All of these versions come by the name OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE. Given below are the details of the strengths of this generic introduced by Endo Operations.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 5MG BASE; 12.5MG; 20MG | tablet | Prescription | ORAL | AB | Oct 26, 2016 |
| EQ 5MG BASE; 12.5MG; 40MG | tablet | Prescription | ORAL | AB | Oct 26, 2016 |
| EQ 5MG BASE; 25MG; 40MG | tablet | Prescription | ORAL | AB | Oct 26, 2016 |
| EQ 10MG BASE; 12.5MG; 40MG | tablet | Prescription | ORAL | AB | Oct 26, 2016 |
| EQ 10MG BASE; 25MG; 40MG | tablet | Prescription | ORAL | AB | Oct 26, 2016 |
2. PIRAMAL
Piramal Healthcare Uk Ltd has filed for 5 different strengths of generic version for Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil. All of these versions come by the name OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE. Given below are the details of the strengths of this generic introduced by Piramal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 10MG BASE; 25MG; 40MG | tablet | Prescription | ORAL | AB | May 14, 2025 |
| EQ 5MG BASE; 12.5MG; 40MG | tablet | Prescription | ORAL | AB | May 14, 2025 |
| EQ 5MG BASE; 25MG; 40MG | tablet | Prescription | ORAL | AB | May 14, 2025 |
| EQ 10MG BASE; 12.5MG; 40MG | tablet | Prescription | ORAL | AB | May 14, 2025 |
| EQ 5MG BASE; 12.5MG; 20MG | tablet | Prescription | ORAL | AB | May 14, 2025 |
3. TEVA PHARMS USA
Teva Pharmaceuticals Usa has filed for 5 different strengths of generic version for Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil. All of these versions come by the name OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 5MG BASE; 12.5MG; 40MG | tablet | Prescription | ORAL | AB | Nov 3, 2016 |
| EQ 5MG BASE; 25MG; 40MG | tablet | Prescription | ORAL | AB | Nov 3, 2016 |
| EQ 5MG BASE; 12.5MG; 20MG | tablet | Prescription | ORAL | AB | Nov 3, 2016 |
| EQ 10MG BASE; 12.5MG; 40MG | tablet | Prescription | ORAL | AB | Nov 3, 2016 |
| EQ 10MG BASE; 25MG; 40MG | tablet | Prescription | ORAL | AB | Nov 3, 2016 |
4. TORRENT
Torrent Pharmaceuticals Ltd has filed for 5 different strengths of generic version for Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil. All of these versions come by the name OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE. Given below are the details of the strengths of this generic introduced by Torrent.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 5MG BASE; 25MG; 40MG | tablet | Prescription | ORAL | AB | Oct 26, 2016 |
| EQ 5MG BASE; 12.5MG; 20MG | tablet | Prescription | ORAL | AB | Oct 26, 2016 |
| EQ 5MG BASE; 12.5MG; 40MG | tablet | Prescription | ORAL | AB | Oct 26, 2016 |
| EQ 10MG BASE; 12.5MG; 40MG | tablet | Prescription | ORAL | AB | Oct 26, 2016 |
| EQ 10MG BASE; 25MG; 40MG | tablet | Prescription | ORAL | AB | Oct 26, 2016 |
Manufacturing Plant Locations New
Torrent's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Torrent as present at those locations.
| Country | City | Firm Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||
| United States |
| |||||||||||